Cresco Labs (CRLBF) Non-Current Deferred Tax Liability (2019 - 2026)

Cresco Labs has reported Non-Current Deferred Tax Liability for 8 years, with the latest figure at $66.1 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Deferred Tax Liability fell 8.87% year-over-year to $66.1 million; the trailing twelve-month figure through Mar 2026 stood at $66.1 million (down 8.87% YoY), and the FY2025 full-year result was $71.6 million, changed N/A from the prior year.
• Non-Current Deferred Tax Liability for Q1 2026 stood at $66.1 million, down from $71.6 million in the prior quarter.
• The five-year high for Non-Current Deferred Tax Liability was $89.4 million in Q4 2023, with the low at $40.9 million in Q3 2024.
• Historically, Non-Current Deferred Tax Liability has averaged $67.7 million across 5 years, with a median of $72.6 million in 2025.
• Annual changes were most pronounced in 2022 — Non-Current Deferred Tax Liability soared 93.39% — and 2024, when it slumped 44.9%.
• Cresco Labs' Non-Current Deferred Tax Liability stood at $75.1 million in 2022, then increased by 18.99% to $89.4 million in 2023, then plunged by 54.27% to $40.9 million in 2024, then jumped by 75.12% to $71.6 million in 2025, then dropped by 7.66% to $66.1 million in 2026.
• The last three Non-Current Deferred Tax Liability figures came in at $66.1 million (Q1 2026), $71.6 million (Q4 2025), and $72.6 million (Q3 2025), per Business Quant data.